Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

25.34
-6.0900-19.38%
Post-market: 24.92-0.4200-1.66%19:57 EDT
Volume:246.48K
Turnover:6.65M
Market Cap:42.28M
PE:- -
High:31.43
Open:29.49
Low:25.22
Close:31.43
52wk High:152.22
52wk Low:11.52
Shares:1.67M
Float Shares:1.67M
Volume Ratio:0.73
T/O Rate:14.77%
Dividend:3.85
Dividend Rate:15.19%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Tempus - Consideration Structured as 100% Stock, Cash Option Capped at 50%

THOMSON REUTERS
·
Jul 20

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (mrd) into Its Ai-enabled Precision Oncology Platform

THOMSON REUTERS
·
Jul 20

Tempus AI Inc - Cash Consideration Will be Financed with Cash on Hand and Borrowings Under Company's Then Existing Credit Facilities

THOMSON REUTERS
·
Jul 20

Dimon Warns AI Risks

AI Industry Frontlines
·
Jul 17

How Do Tempus AI’s (TEM) NHS Prostate Results Shape Its Clinical Credibility Narrative?

Simply Wall St.
·
Jul 17

AI Trading Has Become a 'Rubber Band,' Goldman Sachs Top Trader: The Question is 'When Will It Snap'

AI Industry Frontlines
·
Jul 17

AI Market Outlook; The Era Of Risk-Free Gains Has Come To An End

AI Industry Frontlines
·
Jul 17

Tempus Cites Real-world UK NHS Study Showing Prostate Pathology AI Changes Diagnosis in 5% of Cases

Reuters
·
Jul 16

Tempus AI is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 16

Tempus AI price target raised to $71 from $68 at TD Cowen

TIPRANKS
·
Jul 15

Anthropic Delays Claude Fable 5 Billing; OpenAI Removes GPT-5.6 Sol Usage Caps

AI Industry Frontlines
·
Jul 13

Tempus AI CEO, Data Ryan Fukushima Reports Disposal of $1.91 Million in Common Shares

Reuters
·
Jul 11

Morgan Stanley Remains a Buy on Tempus AI, Inc. Class A (TEM)

TIPRANKS
·
Jul 10

Nancy Pelosi, Donald Trump Bet On The Same 10 Stocks – Some Might Surprise You

Tech News Roundup
·
Jul 10

Pfizer Stock Leads 3 AI Healthcare Picks Worth A Closer Look

Simply Wall St.
·
Jul 10

Tempus AI Schedules Q2 2026 Financial Results Release for July 30

Deep News
·
Jul 09

Tempus AI to Report Q2 Results, Host Conference Call

Reuters
·
Jul 09

Tempus AI CEO, Data Ryan Fukushima Reports Disposal of 10,000 Common Shares Worth $600,000

Reuters
·
Jul 09

How Investors May Respond To Tempus AI (TEM) Refocusing From Lab Tests To AI Research Partnerships

Simply Wall St.
·
Jul 09

Biovica Refocuses US Commercial Strategy, Terminates Deal with Tempus AI

Reuters
·
Jul 06